title: Neurotoxins and neurotoxicity mechanisms. An overview.
abstract: Neurotoxins represent unique chemical tools, providing a means to 1) gain insight into cellular mechanisms of apopotosis and necrosis, 2) achieve a morphological template for studies otherwise unattainable, 3) specifically produce a singular phenotype of denervation, and 4) provide the starting point to delve into processes and mechanisms of nerve regeneration and sprouting. There are many other notable uses of neurotoxins in neuroscience research, and ever more being discovered each year. The objective of this review paper is to highlight the broad areas of neuroscience in which neurotoxins and neurotoxicity mechanism come into play. This shifts the focus away from neurotoxins per se, and onto the major problems under study today. Neurotoxins broadly defined are used to explore neurodegenerative disorders, psychiatric disorders and substance use disorders. Neurotoxic mechanisms relating to protein aggregates are indigenous to Alzheimer disease, Parkinson's disease. NeuroAIDS is a disorder in which microglia and macrophages have enormous import. The gap between the immune system and nervous system has been bridged, as neuroinflammation is now considered to be part of the neurodegenerative process. Related mechanisms now arise in the process of neurogenesis. Accordingly, the entire spectrum of neuroscience is within the purview of neurotoxins and neurotoxicity mechanisms. Highlights on discoveries in the areas noted, and on selective neurotoxins, are included, mainly from the past 2 to 3 years.
authors.affiliation: Molecular and Clinical Pharmacology, ICBM, Faculty of Medicine, University of Chile, Casilla 70000, Santiago, Chile. jsegura@med.uchile.cl
authors.forename: Juan
authors.initials: J
authors.lastname: Segura-Aguilar
authors.forename: Richard M
authors.initials: RM
authors.lastname: Kostrzewa
mesh_terms: D000818:Animals; D004777:Environment; D006801:Humans; D009420:Nervous System / Q000254:growth & development; D018696:Neuroprotective Agents / Q000627:therapeutic use; D020258:Neurotoxicity Syndromes / Q000188:drug therapy / Q000235:genetics / Q000473:pathology / Q000503:physiopathology*; D009498:Neurotoxins / Q000633:toxicity*; D019966:Substance-Related Disorders / Q000503:physiopathology
chemical_list: D018696:Neuroprotective Agents; D009498:Neurotoxins